Paul Ehrlich was a German physician and a gifted researcher in the fields of microbiology, cell physiology, and immunology and was later called the father of chemotherapy. After studies and expeditions to Egypt and other countries and due to the personal experience to be infected with tuberculosis, he joined in 1891 the research group of Robert
Koch at the Berlin Institute of Infectious Diseases, where he met famous coworkers (e.g.,
Kitasato) and cooperated with Emil von
Behring. In 1896, a special institute was created there for Ehrlich’s research field (Institute for Serum Research and Serum Testing). His main discoveries were:
Development of a dye (Gram staining), which made it possible to diagnose the different blood cells (this stain is still used today).
He worked successfully on the phenomena of acquired immunity and autoimmunity. His work was considered so important that he was awarded in 1908 with the Nobel Prize in Physiology or Medicine with respect to his results in...
Blood Cell Infectious Disease Research Group Research Field Chemical Compound
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Ehrlich P (1910) Anwendung und Wirkung von Salvarsan. Dt Med Wschr 35:2437–2438Google Scholar
Ehrlich P, Wassermann A (1894) Über die Anwendung der Diphtherieantitoxine aus Blutserum und Milch immunisierter Thiere. Hyg Rundschau 24:240–250Google Scholar
Ehrlich P et al (1894) Ueber Gewinnung und Verwendung des Diphtherieheilserums. Dt Med Wschr 20:353–355CrossRefGoogle Scholar
Ho EL, Lukehast SA (2011) Syphilis: using modern approaches to understand an old disease. J Clin Invest 12:4584–4592CrossRefGoogle Scholar